Incidence of acquired demyelinating syndromes of the CNS in Dutch children: A nationwide study

Acquired demyelinating syndromes (ADS) can be a first presentation of multiple sclerosis (MS) in children. The incidence of these disorders in Europe is currently unknown. Children (<18 years old) living in the Netherlands who presented with ADS were included from January 1, 2007 to December 31, 2010 by the Dutch pediatric MS study group and the Dutch surveillance of rare pediatric disorders. Demographic and clinical data were collected. Eighty-six patients were identified over 4 years, resulting in an incidence of 0.66/1,00,000 per year. Most patients presented with polyfocal ADS without e... Mehr ...

Verfasser: Ketelslegers, I.A. (Immy)
Catsman-Berrevoets, C.E. (Coriene)
Neuteboom, R.F. (Rinze)
Boon, M. (Martin)
Dijk, K.G.J. (K. G J) van
Eikelenboom, M.J. (Merijn Judith)
Gooskens, R.H.J.M. (Rob)
Niks, E.H. (Erik)
Overweg-Plandsoen, W.C.G.
Peeters, E.A. (Els)
Peeters-Scholte, C.M.P.C.D. (Cacha)
Poll-The, B.T.
De Rijk-Van Andel, J. (Johanneke)
Samijn, J.P. (Johnny)
Snoeck, M.M.J. (M. M J)
Stroink, H. (Hans)
Vermeulen, R.J. (Jeroen)
Verrips, A. (Aad)
Vles, J.S.H. (Johannes)
Willemsen, M.A. (Michél)
Rodrigues Pereira, R.
Hintzen, R.Q. (Rogier)
Dokumenttyp: Artikel
Erscheinungsdatum: 2012
Schlagwörter: Demyelinating diseases / Incidence / Multiple sclerosis / Pediatric
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-29035681
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://repub.eur.nl/pub/63424

Acquired demyelinating syndromes (ADS) can be a first presentation of multiple sclerosis (MS) in children. The incidence of these disorders in Europe is currently unknown. Children (<18 years old) living in the Netherlands who presented with ADS were included from January 1, 2007 to December 31, 2010 by the Dutch pediatric MS study group and the Dutch surveillance of rare pediatric disorders. Demographic and clinical data were collected. Eighty-six patients were identified over 4 years, resulting in an incidence of 0.66/1,00,000 per year. Most patients presented with polyfocal ADS without encephalopathy (30%), followed by polyfocal ADS with encephalopathy (24%), optic neuritis (ON, 22%), monofocal ADS (16%), transverse myelitis (3%), and neuromyelitis optica (3%). Patients with polyfocal ADS with encephalopathy were younger (median 3.9 years) than patie